How to Incorporate Subcutaneous Infliximab and Vedolizumab in Your Practice

Clin Gastroenterol Hepatol. 2024 Oct 8:S1542-3565(24)00822-X. doi: 10.1016/j.cgh.2024.07.042. Online ahead of print.
No abstract available